Literature DB >> 6662138

Hereditary hypofibrinogenemia with fibrinogen storage in the liver.

H Wehinger, O Klinge, E Alexandrakis, J Schürmann, J Witt, H H Seydewitz.   

Abstract

A family with hereditary autosomal dominant hypofibrinogenemia is described. The outstanding feature is massive deposition of fibrinogen/fibrin within hepatocytes, faintly visible in routine microscopic sections, but clearly demonstrable by immunohistologic techniques. Circulating fibrinogen shows normal electrophoretic mobility of A alpha-, B beta-, and gamma-chains. We assume that the hereditary defect in this family interferes with fibrinogen release from hepatocytes. Clinically there are fluctuating slight elevations of serum transaminase levels. Hemostasis and wound healing are undisturbed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6662138     DOI: 10.1007/bf00496800

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  6 in total

1.  STUDIES ON THE PHYSIOLOGICAL ACTIVITY OF THE PEPTIDE RELEASED DURING THE FIBRINOGEN-FIBRIN CONVERSION.

Authors:  A J OSBAHR; J A GLADNER; K LAKI
Journal:  Biochim Biophys Acta       Date:  1964-06-08

2.  Dysfibrinogenemia associated with hepatoma. Increased carbohydrate content of the fibrinogen molecule.

Authors:  H R Gralnick; H Givelber; E Abrams
Journal:  N Engl J Med       Date:  1978-08-03       Impact factor: 91.245

3.  Dysfibrinogenemia associated with liver disease.

Authors:  J E Palascak; J Martinez
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

4.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

5.  Intracisternal hyalin in hepatocytes of human liver biopsies.

Authors:  U Pfeifer; O Klinge
Journal:  Virchows Arch B Cell Pathol       Date:  1974

6.  Fibrinogen Philadelphia. A hereditary hypodysfibrinogenemia characterized by fibrinogen hypercatabolism.

Authors:  J Martinez; R R Holburn; S S Shapiro; A J Erslev
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

  6 in total
  6 in total

1.  Fibrinogen brescia: hepatic endoplasmic reticulum storage and hypofibrinogenemia because of a gamma284 Gly-->Arg mutation.

Authors:  S O Brennan; J Wyatt; D Medicina; F Callea; P M George
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

2.  Quasi-static acoustic tweezing thromboelastometry.

Authors:  R G Holt; D Luo; N Gruver; D B Khismatullin
Journal:  J Thromb Haemost       Date:  2017-06-09       Impact factor: 5.824

3.  Fibrinogen storage disease without hypofibrinogenemia associated with estrogen therapy.

Authors:  Z Simsek; O Ekinci; M Cindoruk; T Karakan; B Degertekin; G Akyol; S Unal
Journal:  BMC Gastroenterol       Date:  2005-11-15       Impact factor: 3.067

Review 4.  Hepatic and Extrahepatic Sources and Manifestations in Endoplasmic Reticulum Storage Diseases.

Authors:  Francesco Callea; Paola Francalanci; Isabella Giovannoni
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

Review 5.  Hereditary Hypofibrinogenemia with Hepatic Storage.

Authors:  Rosanna Asselta; Elvezia Maria Paraboschi; Stefano Duga
Journal:  Int J Mol Sci       Date:  2020-10-22       Impact factor: 5.923

Review 6.  The Discovery of Endoplasmic Reticulum Storage Disease. The Connection between an H&E Slide and the Brain.

Authors:  Francesco Callea; Valeer Desmet
Journal:  Int J Mol Sci       Date:  2021-03-12       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.